1/12
07:20 am
cdna
CareDx Announces Preliminary Fourth Quarter and Full Year 2025 Financial Results [Yahoo! Finance]
High
Report
CareDx Announces Preliminary Fourth Quarter and Full Year 2025 Financial Results [Yahoo! Finance]
1/12
07:05 am
cdna
CareDx Announces Preliminary Fourth Quarter and Full Year 2025 Financial Results
High
Report
CareDx Announces Preliminary Fourth Quarter and Full Year 2025 Financial Results
1/7
07:21 am
cdna
CareDx and 10x Genomics to Launch ImmuneScape™ Program – A Multiomics Research Platform to Decode Transplant Rejection and Drug Response [Yahoo! Finance]
Low
Report
CareDx and 10x Genomics to Launch ImmuneScape™ Program – A Multiomics Research Platform to Decode Transplant Rejection and Drug Response [Yahoo! Finance]
1/7
07:05 am
cdna
CareDx and 10x Genomics to Launch ImmuneScape™ Program – A Multiomics Research Platform to Decode Transplant Rejection and Drug Response
Low
Report
CareDx and 10x Genomics to Launch ImmuneScape™ Program – A Multiomics Research Platform to Decode Transplant Rejection and Drug Response
1/6
08:06 am
cdna
CareDx (NASDAQ:CDNA) was downgraded by analysts at Craig Hallum from a "buy" rating to a "hold" rating.
Low
Report
CareDx (NASDAQ:CDNA) was downgraded by analysts at Craig Hallum from a "buy" rating to a "hold" rating.
12/26
04:05 pm
cdna
CareDx Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Low
Report
CareDx Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
12/22
10:17 am
cdna
CareDX Has Reached An Inflection Point, But Regulatory Risks Remain (Upgrade) [Seeking Alpha]
Low
Report
CareDX Has Reached An Inflection Point, But Regulatory Risks Remain (Upgrade) [Seeking Alpha]
12/21
01:08 am
cdna
Low
Report
12/18
05:45 pm
cdna
CareDx Provides Notice of Proposed Derivative Settlement [Yahoo! Finance]
Low
Report
CareDx Provides Notice of Proposed Derivative Settlement [Yahoo! Finance]
12/18
05:00 pm
cdna
CareDx Provides Notice of Proposed Derivative Settlement
Low
Report
CareDx Provides Notice of Proposed Derivative Settlement
12/15
08:43 am
cdna
CareDx (NASDAQ:CDNA) was given a new $18.00 price target on by analysts at Wells Fargo & Company.
Low
Report
CareDx (NASDAQ:CDNA) was given a new $18.00 price target on by analysts at Wells Fargo & Company.
12/14
12:17 pm
cdna
CareDx (CDNA): Rethinking Valuation After a Sharp Short-Term Share Price Rebound [Yahoo! Finance]
Medium
Report
CareDx (CDNA): Rethinking Valuation After a Sharp Short-Term Share Price Rebound [Yahoo! Finance]
11/24
04:05 pm
cdna
SHORE Study Demonstrates HeartCare's Prognostic Value for Heart Transplant Recipients, Published in Journal of Heart and Lung Transplantation
Low
Report
SHORE Study Demonstrates HeartCare's Prognostic Value for Heart Transplant Recipients, Published in Journal of Heart and Lung Transplantation
11/20
01:33 pm
cdna
CareDx (NASDAQ:CDNA) had its "hold (c-)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
CareDx (NASDAQ:CDNA) had its "hold (c-)" rating reaffirmed by analysts at
Weiss Ratings.
11/20
06:01 am
cdna
CareDx (NASDAQ:CDNA) was upgraded by analysts at Zacks Research from a "strong sell" rating to a "hold" rating.
Low
Report
CareDx (NASDAQ:CDNA) was upgraded by analysts at Zacks Research from a "strong sell" rating to a "hold" rating.
11/10
08:00 am
cdna
CareDx to Participate in Upcoming Investor Conferences
Medium
Report
CareDx to Participate in Upcoming Investor Conferences
11/9
01:11 am
cdna
CareDx (NASDAQ:CDNA) was upgraded by analysts at
Weiss Ratings from a "sell (d+)" rating to a "hold (c-)" rating.
Medium
Report
CareDx (NASDAQ:CDNA) was upgraded by analysts at
Weiss Ratings from a "sell (d+)" rating to a "hold (c-)" rating.
11/7
04:34 pm
cdna
CareDx Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) [Yahoo! Finance]
Medium
Report
CareDx Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) [Yahoo! Finance]
11/7
04:05 pm
cdna
CareDx Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Medium
Report
CareDx Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
11/6
08:10 am
cdna
CareDx (NASDAQ:CDNA) had its price target raised by analysts at BTIG Research from $22.00 to $25.00. They now have a "buy" rating on the stock.
Medium
Report
CareDx (NASDAQ:CDNA) had its price target raised by analysts at BTIG Research from $22.00 to $25.00. They now have a "buy" rating on the stock.
11/6
08:00 am
cdna
CareDx Announces New Precision Kidney Transplant Data and Product Innovations at ASN Kidney Week 2025
High
Report
CareDx Announces New Precision Kidney Transplant Data and Product Innovations at ASN Kidney Week 2025
11/4
10:23 pm
cdna
CareDx, Inc (CDNA) Q3 2025 Earnings Call Transcript [Seeking Alpha]
Low
Report
CareDx, Inc (CDNA) Q3 2025 Earnings Call Transcript [Seeking Alpha]
11/4
05:19 pm
cdna
CareDx: Q3 Earnings Snapshot [Yahoo! Finance]
Low
Report
CareDx: Q3 Earnings Snapshot [Yahoo! Finance]
11/4
04:05 pm
cdna
CareDx Announces Third Quarter 2025 Financial Results
Medium
Report
CareDx Announces Third Quarter 2025 Financial Results
10/28
01:31 am
cdna
Low
Report